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SUMMARY
1. Intracellular Ca
2+ overload has been associated with
established atrial arrhythmogenesis. The present experiments
went on to correlate acute initiation of atrial arrhythmogenesis
in Langendorff-perfused mouse hearts with changes in Ca
2+
homeostasis in isolated atrial myocytes following pharmacological
procedures that modiﬁed the storage or release of sarcoplasmic
reticular (SR) Ca
2+ or inhibited entry of extracellular Ca
2+.
2. Caffeine (1 mmol/L) elicited diastolic Ca
2+ waves in regularly
stimulated atrial myocytes immediately following addition.
This was followed by a decline in the amplitude of the evoked
transients and the disappearance of such diastolic events,
suggesting partial SR Ca
2+ depletion.
3. Cyclopiazonic acid (CPA; 0.15 lmol/L) produced more
gradual reductions in evoked Ca
2+ transients and abolished
diastolic Ca
2+ events produced by the further addition of caffeine.
4. Nifedipine (0.5 lmol/L) produced immediate reductions in
evoked Ca
2+ transients. Further addition of caffeine produced an
immediate increase followed by a decline in the amplitude of the
evoked Ca
2+ transients, without eliciting diastolic Ca
2+ events.
5. These ﬁndings correlated with changes in spontaneous and
provoked atrial arrhythmogenecity in mouse isolated Langendorf-
perfused hearts. Thus, caffeine was pro-arrhythmogenic immediately
following but not > 5 min after application and both CPA and
nifedipine pretreatment inhibited such arrhythmogenesis.
6. Together, these ﬁndings relate acute atrial arrhythmogenesis
in intact hearts to diastolic Ca
2+ events in atrial myocytes that,
in turn, depend upon a ﬁnite SR Ca
2+ store and diastolic Ca
2+
release following Ca
2+-induced Ca
2+ release initiated by the entry
of extracellular Ca
2+.
Key words: atrial arrhythmogenesis, Ca
2+ homeostasis,
murine hearts.
INTRODUCTION
Atrial arrhythmias constitute the most common sustained disorders
of cardiac rhythm encountered in clinical practice. For example,
atrial ﬁbrillation (AF) is associated with substantial mortality and
morbidity from stroke, thromboembolism, heart failure and impaired
quality of life.
1 Established atrial arrhythmogenesis has been asso-
ciated with intracellular Ca
2+ overload.
2 Clinical and experimental
studies report that atrial myocytes in situations of established AF
and accompanying atrial hypertrophy,
3 as well as in conditions such
as congestive cardiac failure,
4,5 show increased spontaneous diasto-
lic Ca
2+ release from the sarcoplasmic reticulum (SR). However, the
precise cause-and-effect relationships between atrial arrhythmo-
genecity, any accompanying anatomical or functional remodelling
and changes in SR Ca
2+ release remain unclear. Consequently, the
mechanisms involved in the initiation or termination, particularly of
acute, as opposed to established, AF remain poorly understood. This
acute situation is exempliﬁed by the condition of catecholaminergic
polymorphic ventricular tachycardia (CPVT), associated with
cardiac ryanodine receptor (RyR2) mutations that result in episodic
atrial arrhythmias, including sinus bradycardia, junctional rhythms
and AF, in addition to ventricular tachyarrhythmias. These are
initiated by stress and adrenergic stimulation, despite the absence
of anatomical abnormalities.
6,7
Rather than considering established atrial arrhythmogenesis, the
present paper is concerned with the possible roles of pharmacological
changes to cellular Ca
2+ homeostasis in the acute initiation of atrial
arrhythmogenecity in otherwise functionally and structurally normal
hearts. Previous studies on atrial systems have not made such
correlations.
8–10 Mouse rather than canine,
4 rabbit
11 or rat hearts
9
were used in view of their potential importance in providing genetic
arrhythmic models, as has been the case for ventricular arrhythmogenesis
in LQTS3,
12 Brugada syndrome
13 and CPVT.
14–16 Rather than using
pulmonary vein preparations, which also include smooth and
pacemaker-like cells, we studied isolated atrial myocytes, which include
smooth and pacemaker-like cells in addition to atrial myocyte-like
cells.
17 Thus, our approach required modiﬁcations in both atrial
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for confocal Ca
2+ imaging and a separation of atrial from ventricular
electrophysiological activity in intact Langendorf-perfused mouse
hearts through a range of pacing conditions.
METHODS
Inbred 129/Sv wild-type mice (Harlan, Bicester, UK) were kept in an animal
house at room temperature under a 12 h light–dark cycle and fed sterile
rodent chow with constant access to water. All procedures conformed to
the UK Animals (Scientiﬁc Procedures) Act (1986).
Solutions
The following solutions were used during the course of the preparation and
experimental procedures. Solution A for electrophysiological experiments on
Langendorff-perfused hearts consisted of normal bicarbonate-buffered
Krebs’–Henseleit (KH) solution (composition (in mmol/L): NaCl 119;
NaHCO3 2 5 ;K C l4 . 0 ;K H 2PO4 1.2; MgCl2 1.0; CaCl2 1.8; glucose 10; sodium
pyruvate 2.0) maintained at pH 7.4 by bubbling with 95% O2–5% CO2
(British Oxygen, Manchester, UK). Solution B was the basic solution from
which other solutions used in the myocyte isolation procedure were derived
(composition (in mmol/L): NaCl 125; KCl 4.75; MgSO4 1.2; KH2PO4 1.2;
HEPES 30; glucose 10; taurine 50, titrated to pH 7.4 with NaOH). The
solution was ﬁltered through a 0.2 lm ﬁlter (Millipore, Billerica, MA, USA)
to remove microbes and small particles. This provided the stock solution for
the production of Solutions C–H used during myocyte isolation.
1. Solution C: this 750 lmol/L Ca
2+-containing perfusion solution was
prepared by adding 750 lmol/L CaCl2 to Solution B.
2. Solution D: this Ca
2+-free nitrilotriacetic acid (NTA)-containing solution
was prepared by adding 5 mmol/L NTA to Solution B and titrating the resulting
solution to pH 6.95 with NaOH.
3. Solution E: an enzyme solution prepared by adding 1.5 mg/mL collagenase
(Worthington Type II), 2 mg/mL hyaluronidase (Sigma, Gillingham, Dorset,
UK) and 100 lmol/L CaCl2 to Solution B.
4. Solution F: this was a further digestion buffer made by adding 1 mg/mL
collagenase and 1 mg/mL bovine servum albumin (BSA) to Solution B.
5. Solution G: this was an enzyme washout solution made by adding 1 mg/mL
BSA and 250 lmol/L CaCl2 to Solution B.
6. Solution H: this Ca
2+-containing solution was made by adding 1.2 mmol/L
CaCl2 to Solution B.
After preparation, Solutions D–G were always ﬁltered using a 0.2 lm ﬁlter to
remove microbes and small particles.
Atrial myocyte isolation
Atrial myocytes were obtained from mice aged 3 months. Single mouse atrial
myocytes used for the imaging of Ca
2+ signals were isolated using an
enzymatic digestion protocol substantially modiﬁed and combined from
previously established procedures.
18,19 Mice were killed by cervical dislocation
(Schedule I, UK Animals (Scientiﬁc Procedures) Act, 1986). Hearts were
then rapidly excised and cannulated in ice-cold Krebs’–Henseleit solution
(Solution A) before mounting onto a Langendorff perfusion system for
perfusion with Solution C (for 4 min), Solution D (4 min) and Solution E
(10–12 min) in sequence at a stable temperature of 37 C. The heart was then
removed from the perfusion apparatus and the atrial appendages were excised
and chopped into several pieces in Solution F. These were further incubated
for another 5–10 min with gentle manual agitation using a 1 mL tip transfer
pipette. All these latter steps were performed at 36–37 C. Cells were then
separated from the enzymatic solution by centrifuging at 243 g for 3 min.
The resulting isolated cells were then washed using Solution G, followed after
5 min by centrifugation at 30 g for 2 min. The cells were then resuspended
in Solution H and, after a 5 min interval, centrifuged again at 30 g for 2 min.
The cells were then maintained at room temperature in Solution H for
the experiments that followed, in common with previous studies in atrial
myocytes.
3,20–22 We observed that cardiac myocytes were more viable studied
under these conditions than at the higher temperatures used when perfusing
whole hearts. Accordingly, our studies sought to investigate the presence or
absence of particular effects, rather than making full quantitative comparisons
between single myocytes and whole hearts.
Confocal microscopy
Cells were then placed on a Grade 1 circular laminin-coated coverslip (Menzel,
Glasbearbeitungswerk, Germany) that formed the ﬂoor of a 1.5 mL perfusion
chamber, to which it was ﬁxed with vacuum grease. Cells were then loaded
with the acetoxymethyl (AM) ester of Fluo-3 (Molecular Probes, Leiden, The
Netherlands) by incubation with 5 lmol/L Fluo-3 AM in Solution H
(1.2 mmol/L CaCl2) for 10–20 min in the dark before washout of the
Fluo-3-containing solution. Cells were then transferred onto the stage of a
Zeiss LSM-510 laser scanning confocal system (Zeiss, Jena, Germany) with
a ·20 air objective on a Zeiss Axiovert 100M inverted microscope. Fluo-3
ﬂuorescence emission was excited with a 488 nm argon laser and measured
at wavelengths between 505 and 550 nm. Images were then analysed using
an in-house custom-made software program. Series of 500 frames
(128 · 64 pixels/frame) were collected at a scanning frequency of 25 msec/
frame to monitor ﬂuorescence changes over time. Fluorescence measurements,
corrected for background signal in regions outside the cells, were made
within deﬁned regions of interest (F) and were normalized to their resting
ﬂuorescence (F0) values. For each of the myocytes studied, peak F/F0 values
were calculated throughout each time series acquired and a mean peak F/F0
was calculated for that series. Where indicated, cells were paced at 1 Hz (5 V
above excitation threshold of 30–60 V for 2 msec) with two ﬁeld electrodes.
All ﬂuorescence studies were performed at room temperature. Ca
2+ transients
were measured both from regions of interest (ROIs) covering entire cells and
from sets of three (1 · 4 pixel; 1 pixel ¼ 0.6 · 0.6 lm) ROIs placed at the
cell margin, the cell centre and regions between these, approximately 2–3 lm
from the surface.
Langendorff preparations for atrial electrophysiological
experiments
The whole-heart experiments used modiﬁcations of previously established
procedures to set up a Langendorff perfusion system for the murine heart.
23–25
Male and female mice (age 3–6 months) were randomly selected and injected
with 50 IU, i.p., heparin 10–15 min before being killed by cervical dislocation
(Schedule I, UK Animals (Scientiﬁc Procedures) Act, 1986). We observed
that hearts from younger mice were signiﬁcantly less amenable to successful
cannulation. The heart was cannulated in situ using a straight-cut and smoothed
21 gauge needle previously ﬁlled with Solution A, dissected and then ﬁxed
securely with a straight 60 g pressure microaneurysm clip (Harvard Apparatus,
Edenbridge, UK). The cannulated heart was perfused with Solution A at room
temperature before being mounted onto a Langendorff system
25 and then
perfused at a constant ﬂow rate of 2–2.5 mL/min (model 505S; Watson-Marlow
Bredel Peristaltic Pumps, Falmouth, Cornwall, UK) with Solution A.
The perfusate was ﬁrst ﬁltered through 200 and 5 lm membranes
(Millipore UK, Watford, UK) and warmed to 37 C by a water-jacketed
heat-exchange coil (Model C-58A; Techne, Cambridge, UK) before entering
the coronary arterial network. The aortic valve was shut by the pressure of
the perfusate that ultimately drained through the vena cava. Viable hearts
regained a pink appearance and spontaneous rhythmic contractions upon
warming. Hearts were perfused retrogradely for not less than 10 min in the
absence of stimulation. Experiments were only performed in intact Langendorff
preparations showing clearcut 1 : 1 atrioventricular (AV) conduction during
the intrinsic activity following cannulation. The in situ cannulation procedure
gave preparations with higher intrinsic rates corresponding to baseline cycle
lengths of 155.0 ± 58.4 msec (n ¼ 33 hearts) and more consistent 1 : 1 AV
conduction (PR intervals of 31.8 ± 5.3 msec; n ¼ 33 hearts) than hearts
cannulated following prior separation and immersion in ice-cold buffer
(220.1 ± 71.6 msec; n ¼ 20 hearts).
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The electrophysiological studies performed in isolated perfused hearts were
designed to distinguish atrial from ventricular bipolar electrogram (BEG)
waveforms and involved comparisons of records from simultaneous
recordings made at two sites. Thus, in addition to the paired platinum
stimulating electrodes placed on the right atrium, two bipolar recording
electrodes of 1 mm interpole spacing were placed on the left atrium and left
ventricle. At the beginning of each experiment, the ventricular recording
electrode was placed at a series of positions at successively greater distances
from the atria until there was no demonstrable atrial far-ﬁeld deﬂection in
the ventricular traces while ensuring persistent far-ﬁeld deﬂections in the
atrial traces. Hearts were initially paced for not less than 5 min at 10 Hz to
permit them to regain their physiological steady state. Three types of pacing
protocols were used: (i) hearts were studied at their intrinsic rates in the
absence of stimulation; (ii) hearts were subject to regular pacing at 10 Hz
using 2 msec square-wave stimuli set at 2· the excitation threshold (Grass
S48 stimulator; Grass-Telefactor, Slough, UK); and (iii) hearts were studied
using a programmed electrical stimulation (PES) procedure adopted from
clinical techniques used previously in ventricular studies
25,26 but recently
introduced in clinical studies of atrial electrophysiology.
27 These began using
standard baseline pacing stimuli at frequencies of 10 Hz for 20 s. Drive trains
of eight paced beats (S1) were each followed by an extra stimulus (S2) every
ninth beat, initially at an S1–S2 interval equal to the pacing interval. Each
subsequent cycle reduced the S1–S2 interval by 1 msec until atrial refractoriness
was reached. The resulting electrogram signals were ampliﬁed, band-pass
ﬁltered (30 Hz to 1 kHz; Gould 2400S; Gould-Nicolet Technologies, Ilford,
Essex, UK) and digitized at a sampling frequency of 5 kHz (CED1401plus;
Cambridge Electronic Design, Cambridge, UK).
The present protocols differed from previous studies on ventricular
arrhythmogenesis
12,13,25 in requiring hearts to be paced from the atria rather
than the ventricles. A pacing rate of 8 Hz permitted atrial escape phenomena
that precluded regular activation by the stimulus train. This was particularly
the case in studies performed in the presence of caffeine. This necessitated
a higher pacing rate of 10 Hz to ensure regular atrial stimulation under all
the pharmacological conditions tested. However, in some hearts, such higher
pacing rates resulted in a gradual development of an AV block. Nevertheless,
withdrawal of the regular pacing allowing a resumption of intrinsic activity,
permitted restoration of normal 1 : 1 AV conduction once pharmacological
agents were withdrawn. These ﬁndings likely relate to refractoriness in the
AV node at high pacing rates. Thus, direct measurements showed that the
atria had shorter refractory periods (24 ± 7 msec; n ¼ 33) than the AV node
(61 ± 12 msec; n ¼ 5).
Statistical analysis
Statistical analysis was performed using a repeated-measures one-way
ANOVA to compare data using SPSS software (SPSS, Chicago, IL, USA).
Results from individual hearts acquired during pharmacological intervention
were compared with their respective untreated controls using one-way
ANOVA for correlated samples (SPSS software). P < 0.05 was considered
signiﬁcant. Cross-tabulations with Chi-squared or Fisher’s exact test were
used as appropriate for categorical variables.
Data are expressed as the mean ± SEM. For experiments with single cells,
n denotes the number of peaks from which F/F0 values were obtained; the
numbers of cells involved are given separately. For experiments in whole
hearts, n denotes the number of whole hearts studied.
Agents
All drugs and other chemical agents were purchased from Sigma-Aldrich
(Poole, UK), unless indicated otherwise. Nifedipine was dissolved in 96%
ethanol to make a 1 mmol/L stock solution, kept wrapped in foil to prevent
light degradation and was kept refrigerated at 4 C. Cyclopiazonic acid (CPA)
was prepared in 96% ethanol to make a 10 mmol/L stock solution and was
stored at –20 C. Final drug concentrations were achieved by dilution
with Solution A for electrophysiological experiments and Solution H for
experiments in single cells. Caffeine was dissolved directly in Solution A
or H, as appropriate, and kept at room temperature.
RESULTS
Ca
2+ transients in resting atrial myocytes
The murine atrial myocytes obtained using our modiﬁed procedure
were viable for up to 6–8 h, appearing elongated with rounded but
tapered ends (length 90.4 ± 35.6 lm (range 59.5–167.4 lm); width
13.1 ± 2.0 lm (range 10.1–17.2 lm); n ¼ 15 cells) with well-deﬁned
striations. We studied a total of 90 cells from seven hearts. Of these
cells, we examined the resting unstimulated properties in approximately
20 cells. The remaining cells were subjected to stimulation protocols
in the absence of (n ¼ 15 cells) or following the addition of caffeine
(n ¼ 16 cells), CPA (n ¼ 10 cells), nifedipine (n ¼ 8 cells), CPA +
caffeine (n ¼ 14 cells) or nifedipine + caffeine (n ¼ 5 cells). Even the
approximately 20 resting, unstimulated, Fluo-3 loaded cells exhibited
two forms of spontaneous Ca
2+ activity, with some cells showing
evidence of both (neither previously reported in normal ventricular
cells
28,29). First, approximately six of 10 cells showed spontaneous
periodic Ca
2+ waves, associated in earlier studies with a propagated
Ca
2+-induced Ca
2+ release (CICR). This was demonstrated by
comparing signals from regularly spaced ROIs (4 · 1 pixels; 1 pixel ¼
0.6 · 0.6 lm) positioned at 2–3 lm intervals along the cell lengths
(ROIs designated from 1 to 8 and labelled as such in Fig. 1a
correspond to arrows marked 1–8 in Fig. 1b). These propagated
along part or all of the cell length (Fig. 1c), at a relatively constant
approximate 89 lm/s, a velocity sufﬁcient to account for previously
reported cellular activation delays attributable to a centripetal
propagation of cell activation.
21 These waves either declined in
amplitude with distance (Fig. 1b) or culminated in a second type of
larger synchronized event involving the entire cell, resulting in peak
F/F0 values as high as approximately 14 (Fig. 1d; ROIs labelled 1–9).
Early and delayed effects of caffeine on Ca
2+ transients
in stimulated atrial myocytes
The following experiments studied Ca
2+ transients in regularly
stimulated (1 Hz) Fluo-3-loaded atrial myocytes exposed to agents
that sought to increase the release of SR Ca
2+ through CICR or to
inhibit SR uptake of cytosolic Ca
2+ or extracellular Ca
2+ entry. In
each cell, Ca
2+ transients were measured from both ROIs covering
entire cells and sets of three (1 · 4 pixel; 1 pixel ¼ 0.6 · 0.6 lm)
ROIs placed at the cell margin, the cell centre and regions between
these, approximately 2–3 lm from the surface. Before the addition
of pharmacological agents, myocytes showed regular successions
of entrained Ca
2+ transients with stable amplitudes of mean F/F0
5.49 ± 0.97 (from n ¼ 176 peaks), determined from ROIs covering the
entire cell area, that decayed to a stable baseline (Fig. 2a,e). These
Ca
2+ transients would be the result of cycles of depolarization-induced
SR Ca
2+ release into the cytosol and its subsequent return from the
cytosol to stores whose magnitudes and time-courses would be
sensitive to manoeuvres affecting either process. The addition of
caffeine at a concentration identical to that used in previous studies
in ventricular myoctyes
28,29 initially resulted in the immediate
appearance of diastolic Ca
2+ transients that were smaller in amplitude
but often more prolonged than the evoked transients (Fig. 2b,c).
These followed 50 of 200 peaks recorded at < 5 min following the
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Atrial arrhythmogenesis in murine hearts 971introduction of caffeine in all 16 regularly stimulated cells studied
(Table 1). The peaks appeared to increase in amplitude from the time
of application to approximately 5 min, consistent with enhanced
Ca
2+ r e l e a s ep r o d u c e db yc a f f e i n ea c t i o no nR y R 2C a
2+ release
channels. This would increase cytosolic Ca
2+,w h i c h ,i nt u r n ,w o u l d
also enhance CICR. However, such diastolic Ca
2+ release would
eventually deplete SR Ca
2+ stores. The latter would be consistent
with the subsequent decline in amplitude and frequency and ﬁnal
disappearance of the diastolic peaks in the succeeding 5–15 min
(Fig. 2d). There was also a progressive decline in peak F/F0 of the
evoked transients to 4.28 ± 0.20, 3.56 ± 0.32, 2.99 ± 0.32, 2.57 ± 0.08
and 2.37 ± 0.08 at 1, 1.5, 2, 5 and 10 min after caffeine addition,
respectively (n ¼ 84, 53, 43, 36 and 88 peaks, respectively), consistent
with a partial depletion of SR Ca
2+ stores (Fig. 2e). There was a
corresponding prolongation of their time-courses evident from
comparisons of control traces and records obtained < 5 min and
Fig. 1 Spontaneous Ca
2+ transients in murine atrial myocytes under resting conditions. (a) Localized 4 · 1 pixel regions of interest (ROIs) spaced at intervals of
2–3 lm along the cell length (1–8). (b) F/F0 records reﬂecting Ca
2+ wave propagation through ROIs (1–8). (c) Series of frames demonstrating initiation
a n ds p r e a do faC a
2+ wave. The ﬁrst frame shows positions of the localized 4 · 1 pixel ROIs (1–9) placed at ﬁxed positions, spaced at intervals of 2–3 lm,
along the cell length. (d) Corresponding F/F0 records from ROIs 1–9.
Fig. 2 Effects of caffeine on Ca
2+
transients from regularly stimulated
atrial myocytes. (a–d) Ca
2+ transients
obtained in a typical control myocyte
(a) and cells 2 (b), 5 (c) and 13 min
(d) after the addition of 1.0 mmol/L
caffeine, showing diastolic transients
(arrows; b,c) and the prolonged
development of a decline in signal
amplitude and a prolongation of
time-course (d). (e) Peak F/F0 values
(mean±SEM) under control conditions
compared with corresponding values
at successively greater intervals (1, 1.5,
2, 5, > 10 min) after the addition of
1.0 mmol/L caffeine. **P<0.01 com-
pared with control. (f) Comparison of
the timecourses of typical Ca
2+
transients under control conditions
(trace a) and < 5 min (trace b) and
> 10 min (trace c) after the addition of
1.0 mmol/L caffeine.
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972 Y Zhang et al.> 10 min after the addition of caffeine (Fig. 2f, traces a–c, respectively)
that was compatible with changes in the period during which there
was a net release of SR Ca
2+. Thus, caffeine progressively lengthened
the full-width half-maxima (FWHM) from 119 ± 8 to 126 ± 16 and
302 ± 42 msec < 5 min and > 10 min after its addition, respectively
(P<0.01; Table 2). All such FWHM readings described here were
obtained from a total of 12 peaks obtained from four cells.
Early and delayed effects of CPA on Ca
2+ transients
The simplest hypothesis describing the above ﬁndings would suggest
that caffeine increases the tendency for SR RyR2 Ca
2+ release
channels to release Ca
2+. However, this would then tend to deplete
SR Ca
2+ content. This would reduce levels of releasable SR Ca
2+.
The latter would, in turn, explain the observed declines in both the
peak amplitude of evoked Ca
2+ transients and the frequency of the
diastolic Ca
2+ transients following longer (> 10 min) exposures to
caffeine. Such a hypothesis was corroborated by the results of
independent pharmacological changes in such SR Ca
2+ stores and
extracellular Ca
2+ entry using CPA and nifedipine, respectively.
Following the addition of CPA, atrial cells showed only nine diastolic
Ca
2+ transients over 130 evoked peaks and then in only three of 10
cells at < 5 min following the addition of CPA (Fig. 3a–c). Reductions
in Ca
2+ signal amplitude occurred only at > 10 min to peak F/F0 of
5.14 ± 1.42 (n ¼ 78 peaks) at 10–15 min and 3.29 ± 0.73 (n ¼ 39
Fig. 3 Effects of cyclopiazonic acid
(CPA) on Ca
2+ transients from regu-
larly stimulated atrial myocytes. (a–d)
Control records (a) compared with
results 2 (b) and 11 min (c) after the
addition of 0.15 lmol/L CPA and the
subsequent addition of 1.0 mmol/L
caffeine (d), showing delayed decreases
in signal amplitude (c) that persist
after the addition of caffeine (d), but
an absence of diastolic Ca
2+ transients.
(e,f) Comparison of the time-course of
Ca
2+ transients obtained under control
conditions (trace a) and < 5 min (trace
b) and > 15 min (trace c) after the
addition of CPA, as well as after the
addition of 1.0 mmol/L caffeine
following CPA pretreatment (trace d).
(g) Peak F/F0 values (mean±SEM)
under control conditions compared with
corresponding values at successively
greater intervals (< 10, 10–15 and
> 15 min) after the addition of
0.15 lmol/L CPA and the further addi-
tion of 1.0 mmol/L caffeine. *P<0.01
compared with control.
Table 1 Occurrence of diastolic calcium release in atrial myocytes
Agent No. cells
showing diastolic
release/total
no. cells
No. peaks Diastolic release
<5m i n >5m i n
Control 0/15 176 0 0
Caffeine 16/16
‡ 200 50*
† 0
CPA 3/10
§ 130 9* 0
Nifedipine 0/8
§ 96 0 0
CPA + caffeine 0/14
§ 179 0 0
Nifedipine + caffeine 0/5
§ 60 0 0
*P < 0.01 compared with control (Chi-squared test);
†P <0 . 0 1c o m p a r e d
with cyclopiazonic acid (CPA; Chi-squared test);
‡P < 0.01 compared with
control and CPA (Fischer’s exact test);
§P > 0.05 compared with control
(Fischer’s exact test).
Table 2 Full-width half-maxima values for Ca
2+ transients obtained from
regularly stimulated atrial myocytes under different conditions
Agents No. peaks FWHM (msec)
Control 12 119 ± 8
Caffeine < 5 min 12 126 ± 16
Caffeine > 5 min 12 302 ± 42*
CPA < 5 min 12 102 ± 17
CPA > 15 min 12 128 ± 11
CPA + caffeine 12 170 ± 13*
Nifedipine 12 114 ± 19
Nifedipine + caffeine 12 173 ± 24*
Data are the mean±SEM of results based on 12 peaks obtained from four
cells in each experimental group. *P<0.01 compared with control.
FWHM, full-width half-maxima. CPA, cyclopiazonic acid.
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Atrial arrhythmogenesis in murine hearts 973peaks) at > 15 min, respectively (Fig. 3c,g), consistent with the more
gradual reduction of SR Ca
2+ expected from inhibition of Ca
2+-ATPase
mediated Ca
2+ reuptake. The FWHM values remained unchanged
(102 ± 17 msec at 5 min and 128 ± 11 msec at 15 min; P > 0.05;
Fig. 3e), conﬁrming expectations that CPA should not affect Ca
2+
release kinetics. Further addition of caffeine now produced neither
diastolic Ca
2+ peaks nor further changes in peak F/F0: the peak F/F0
values in cells treated with CPA + caffeine, caffeine alone (> 10 min)
and CPA alone (> 15 min) were statistically similar at 2.61 ± 0.13
(n ¼ 52 peaks), 2.37 ± 0.08 (n ¼ 88 peaks) and 3.29 ± 0.73 (n ¼ 39
peaks), respectively (Fig. 3g), but FWHM was prolonged to
170 ± 13 msec (Fig. 3f) relative to either untreated controls (Fig. 3e,f,
trace a in each) or CPA-pretreated cells (P<0.01), consistent with
effects of caffeine in prolonging Ca
2+ release (Table 2).
Fig. 4 Effects of nifedipine on Ca
2+
transients from regularly stimulated
atrial myocytes. (a–d) Ca
2+ transients
in a typical control myocyte (a), in a
0.5 lmol/L nifedipine-treated atrial
myocyte (b) and in myocytes 2 (c) and
10 min (d) after the further addition of
1.0 mmol/L caffeine. (e) Peak F/F0
values (mean±SEM) under control
conditions compared with corre-
sponding values in the presence of
nifedipine (Nif) and < 5 min and 5–
10 min after the further addition of
caffeine. **P<0.01 compared with
control. (f) Comparisons of the time-
courses of Ca
2+ transients obtained
under control conditions (trace a)
and following addition of nifedipine
(0.5 lmol/L) before (trace b) and after
(trace c) the further addition of caffeine.
Fig. 5 Spatial heterogeneities in evoked
atrial Ca
2+ transients. Spatial hetero-
geneities were analysed by three 4 · 1
pixel regions of interest (ROIs; 1, 2
and 3) placed at successively increasing
distances from the cell margin to the
cell centre at approximately 2–3 lm
intervals. (a) Typical results from a
control atrial myocyte showing sig-
niﬁcant F/F0 spatial heterogeneities, as
reﬂected in the corresponding traces
(1–3), with the highest peak F/F0 at
the cell margin and the lowest F/F0
at the cell centre. (b) Ca
2+ transients
obtained 13 min after the addition of
1.0 mmol/L caffeine. (c,d) Ca
2+ tran-
sients obtained 20 min after the
addition of 0.15 lmol/L CPA before
(c) and after (d) the addition of
1.0 mmol/L caffeine. (e,f) Ca
2+
transients obtained in the presence of
0.5 lmol/L nifedipine before (e) and
after (f) the addition of 1.0 mmol/L
caffeine.
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2+ transients
Experiments that examined the dependence of the diastolic Ca
2+ tran-
sients induced by caffeine on extracellular Ca
2+ entry demonstrated
that nifedipine produced a prompt decrease in peak F/F0 (to
2.38 ± 0.19; n ¼ 96 peaks; Fig. 4a,b), with no changes in FWHM
(114 ± 19 msec; P > 0.05; Fig. 4f, trace b) relative to control traces
(Fig. 4f, trace a), suggesting that it left Ca
2+ release kinetics intact.
Although further addition of caffeine increased peak F/F0 amplitudes
to 2.90 ± 0.39 (n ¼ 60 peaks), it did not result in the appearance of
diastolic Ca
2+ transients (Fig. 4c,d), but did produce an accentuated
decline in peak F/F0 (to 1.65 ± 0.26; n ¼ 36 peaks; Fig. 4e) and a
prolongation of FWHM to 122 ± 18 msec (P > 0.05) at approximately
5m i na n dt o1 7 3±2 4m s e c( P<0.01) at 10 min (Fig. 4f).
Spatial variations in Ca
2+ signalling during
pharmacological treatment
Previous studies have implicated major participation of a propagated,
centripetal CICR initiated by surface Ca
2+ entry in atrial excitation–
contraction coupling, which results in spatial gradients in Ca
2+
signalling with distance from the cell surface.
21 Changes in such
gradients provide a useful indication of the Ca
2+ sensitivity of the CICR
process responsible for atrial activation. Therefore, in the present study,
Ca
2+ transients were measured from sets of three (1 · 4p i x e l ;1
pixel ¼ 0.6 · 0.6 lm) ROIs placed at the cell margin, the cell centre
and regions between these, approximately 2–3 lm from the surface.
The present ﬁndings are compatible with an effect of caffeine in
changing the characteristics of such CICR; such a hypothesis would
predict that caffeine, but not nifedipine or CPA, would enhance its
propagation with distance from the cell surface. Figure 5 exempliﬁes
such predictions. Under control conditions (Fig. 5a), the amplitudes of
evoked Ca
2+ transients obtained from localized 4 · 1 pixel (2.4 ·
0.6 lm) ROIs (Fig. 5a, inset 1, 2 and 3) progressively decreased with
distance from the cell margin, conﬁrming previous reports.
21,30–32 These
heterogeneities persisted in the presence of CPA (Fig. 5c) and nifedipine
(Fig. 5e). However, they were abolished by caffeine whether applied
alone (Fig. 5b) or in combination with either CPA or nifedipine
(Fig. 5d,f), consistent with an action of this agent on a centripetal
propagation of Ca
2+releasethrough a CICR-dependent mechanism.
Fig. 6 Resolution of atrial and ven-
tricular electrogram components
obtained by simultaneous recordings
from two pairs of recording electrodes
placed on the left atrium and left
ventricle, respectively, in control hearts.
(a) Results obtained during intrinsic
activity showing the simultaneously
obtained atrial trace (i) and ventricular
trace (i), in which A1 exempliﬁes
atrial and V1 exempliﬁes ventricular
contributions to the respective electro-
gram waveforms. (b) Results obtained
during regular atrial pacing at 10 Hz.
The atrial trace (i) shows large atrial
deﬂections (A1) following the stimulus
artefacts, followed by smaller ventricular
deﬂections (V1). (c) Results obtained
during programmed electrical stimula-
tion (PES). Traces i and ii illustrate
atrial (A1) and ventricular waveforms
(V1) following each S1 stimulus and
include results from an S2 stimulus
imposed at an interval close to the
atrial refractory period showing neither
atrial nor ventricular deﬂections
following the S2 stimulus despite
normal atrial (A1) and ventricular (V1)
deﬂections in response to the preceding
S1 stimulus.
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intact hearts
The changes in cellular Ca
2+ homeostasis correlated closely with atrial
arrhythmogenic tendency in intact Langendorff-perfused hearts. Control
experiments (n ¼ 34 hearts) assessed whether atrial arrhythmo-
genesis was initiated during 10–15 min of intrinsic activity, 5 min of
regular pacing at 10 Hz and following application of the PES
protocol, with stimulation applied at the right atrium. These control
experiments recorded episodes of either atrial tachycardia (AT),
in the form of a normal sequence of electrical waveforms at increased
frequency, or AF, in the form of irregularly irregular electrical
deﬂections, extending for more than ﬁve deﬂections during intrinsic
or regular pacing and for > 1 s following PES. Similar protocols were
applied in experiments that then involved 20 min pretreatment with
CPA or nifedipine. Experiments that investigated the effect of caffeine
used PES and regular pacing both immediately after and > 5 min
after application; this was in parallel with observations in isolated
myocytes in which diastolic Ca
2+ events were observed immediately
following, but not 5 min after, the addition of caffeine.
Fig. 7 Atrial arrhythmogenic effects of caffeine. (a,b) Traces obtained < 5 min after the addition of 1.0 mmol/L caffeine during programmed electrical
stimulation (PES) showing (a) atrial tachycardia (AT; trace i) and (b) atrial ﬁbrillation (AF; trace i) not apparent in the corresponding ventricular traces (trace
ii). (c) In contrast, arrhythmogenesis was not induced in either atrial (trace i) or ventricular (trace ii) traces > 5 min after the addition of 1.0 mmol/L caffeine.
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activity (Fig. 6a), regular pacing (Fig. 6b) and at the end of a typical
PES procedure in which the S2 stimulus was imposed at an S1–S2
interval close to the atrial refractory period (Fig. 6c). Bipolar
electrogram recordings were obtained not only from the left atria,
but also from the left ventricles. This simultaneous recording made it
possible to distinguish the atrial deﬂections from ventricular far-ﬁeld
artefacts in the atrial records (e.g. Fig. 6b, trace i) Thus, activity in
the atria, did not produce far-ﬁeld deﬂections in the corresponding
ventricular traces owing to the greater distance of the ventricular
electrodes from the atria (Fig. 6b, trace ii). Conversely, the site of the
atrial recording electrodes was comparatively close to the ventricle
and therefore did record its far-ﬁeld deﬂections. Consequently, atrial
BEG recordings showed both atrial and ventricular deﬂections
(Figs 6–8, all traces marked i), but atrial deﬂections were absent
from the ventricular BEG traces (Figs 6–8, all traces marked ii). This
made it possible to separate atrial from ventricular activity and
thereby identify atrial as opposed to ventricular arrhythmogenesis.
Such a comparison demonstrated an absence of either atrial or
ventricular arrhythmogenesis through all the stimulation protocols
explored. In contrast, episodes of AT (Fig. 7a) or AF (Fig. 7b) were
observed during PES immediately following caffeine administration
(n ¼ 11 hearts), but not after > 5 min exposure to caffeine (n ¼ 11
hearts; Fig. 7c) or after CPA (n ¼ 11 hearts; Fig. 8a) or nifedipine
pretreatment (n ¼ 12 hearts; Fig. 8b). Table 3 quantiﬁes these
ﬁndings, demonstrating signiﬁcant (P<0.05, Fisher’s exact test)
Fig. 8 Cyclopiazonic acid (CPA) and nifedipine pretreatment abolish the caffeine-induced arrhythmogenic effect. Atrial (i) and ventricular (ii) electrograms
obtained in experiments with 0.15 lmol/L CPA (a) or 0.5 lmol/L nifedipine (b) pretreatment prior to the addition of 1 mmol/L caffeine during programmed
electrical stimulation. A1, atrial waveform; V1, ventricular waveform.
Table 3 Occurrence of arrhythmogenesis (atrial tachycardia or atrial
ﬁbrillation) under different protocols
Agents Intrinsic (n) Regular pacing
at 10 Hz (n)
PES (n)
Control 0 (34) 0 (34) 4 (34)
Caffeine < 5 min 2 (11) 3 (11)* 5 (11)*
Caffeine > 5 min 0 (11) 0 (11) 0 (11)
CPA pre-treated 0 (11) 0 (11) 1 (11)
C P A+c a f f e i n e 0( 6 ) 0( 6 ) 0( 6 )
Nifedipine pretreated 0 (12) 0 (12) 3 (12)
Nifedipine + caffeine 0 (6) 1 (6) 0 (6)
*P<0.01 compared with control.
PES, programmed electrical stimulation; CPA, cyclopiazonic acid.
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immediately following the addition of caffeine and not with
prolonged caffeine exposure or manoeuvres involving CPA (n ¼ 6
hearts) or nifedipine (n ¼ 6 hearts) pretreatment. These results in
intact hearts precisely parallel the occurrence of diastolic Ca
2+
transients in isolated atrial myocytes.
DISCUSSION
The present study investigated the possible roles of altered Ca
2+
homeostasis in the acute initiation of atrial arrhythmogenesis in
mouse intact hearts. The ﬁndings demonstrated that such arrhyth-
mogenic phenomena depend on both a deﬁnite SR Ca
2+ store and
the diastolic release of Ca
2+. Accordingly, atrial arrhythmogenecity
was increased by pharmacological manipulations that increased SR
Ca
2+ release and this effect was abolished by either inhibiting this
release or depleting SR Ca
2+. Thus, in atrial myocytes, caffeine
produced diastolic Ca
2+ events immediately following, but not > 5 min
after, its application, consistent with an initially increased CICR
subsequently resulting in the partial depletion of a ﬁnite SR Ca
2+
store. Both CPA and nifedipine pretreatment abolished these effects. In
whole hearts, caffeine correspondingly produced pro-arrhythmogenic
effects immediately following, but not > 5 min after, application that
were abolished by CPA or nifedipine pretreatment.
Atrial myocytes show important differences from ventricular
myocytes, particularly in their tubular and SR membrane systems,
which may reﬂect functional differences in their Ca
2+ homeostatic
processes. Atrial myocytes do not possess extensive T-tubular
systems
8,21 and, instead, have prominent transversely orientated SR,
Z-tubular, elements. Atrial cells show an abundant corbular SR
containing non-junctional RyR2.
33 Junctional RyR2–L-type Ca
2+
channel (LTCC) clusters are conﬁned to the cell peripheries.
8 This
may reﬂect atrial activation normally involving CICR in a pattern
of centripetal propagation into the cell interior from superﬁcial T–
SR junctions.
8,21,30 We then examined the acute effects of caffeine
on isolated atrial myocytes. Caffeine is thought to increase the
release of intracellularly stored Ca
2+, either by sensitizing RyR2 to
cytosolic Ca
2+ or inhibiting phosphodiesterase activity, thereby
increasing cellular cAMP
34 and consequently increasing the open
probabilities of the RyR2-channels.
35 Therefore, caffeine would be
expected to initially result in abnormal RyR2-mediated diastolic SR
Ca
2+ release that would subsequently cease with the resulting reduction
in SR Ca
2+, as reported previously for ventricular cells.
36,37
In regularly stimulated single murine atrial myocytes, application
of caffeine resulted in the early appearance of diastolic Ca
2+ release.
However, there was a subsequent disappearance of these events that
was accompanied by a progressive reduction of amplitude, but a
prolongation in time-course, of the evoked Ca
2+ transients with time.
The former observation was consistent with a reduction in store Ca
2+
levels available for release by electrical stimulation consistent with
a delayed reduction of SR Ca
2+ and consistent with earlier studies
that have actually used caffeine as a means of depleting these
stores.
35 Caffeine also abolished spatial heterogeneities in the Ca
2+
transients consistent with actions on the CICR process.
21,30–32,38
These ﬁndings parallel the more frequent spontaneous quantal Ca
2+
release events (sparks) and Ca
2+ waves in atrial cardiomyocytes from
AF patients.
3 Similarly, abnormal function in atrial Ca
2+ release
channels resulting in increased open probabilities and diastolic leak
of Ca
2+ relates to an increased triggered activity in heart failure.
39
These ﬁndings were corroborated by observations from experiments
using the complementary agents CPA and nifedipine. Cyclopiazonic
acid is thought to inhibit Ca
2+-ATPase activity and ultimately reduce
SR Ca
2+.
40 In the present study, CPA pretreatment reduced the
evoked Ca
2+ signals without altering their kinetics or spatial
heterogeneities and inhibited the diastolic Ca
2+ events caused by the
subsequent addition of caffeine. These ﬁndings similarly suggest a
depletion by CPA of SR Ca
2+ releasable by electrical stimulation that
also results in a reduction in caffeine-induced diastolic events.
Nifedipine is a known competitive dihydropyridine LTCC blocker
in ventricular cells with a KD of 40 nmol/L;
23,41 therefore, nifedipine
would be expected to diminish extracellular Ca
2+ entry.
23,25 Nifedipine
produced immediate reductions in evoked Ca
2+ transients while
preserving their kinetics and spatial heterogeneity. Subsequent
addition of caffeine similarly restored the amplitudes of the evoked
Ca
2+ transients, again without the expected induction of diastolic
Ca
2+ transients, consistent with CICR reduced by inhibited entry of
extracellular Ca
2+. These ﬁndings at the cellular level correlate with
the presence or absence of atrial arrhythmogenicity in whole
hearts. The presence or absence of spontaneous and provoked atrial
arrhythmogenesis were examined under conditions of intrinsic and
regular pacing from the right atrium and using programmed electrical
stimulation, respectively. Control hearts showed no evidence of
arrhythmogenicity, whether during intrinsic or regular pacing, and
a low incidence of AT during programmed electrical stimulation,
recapitulating previous clinical observations of brief periods of AT
that follow the imposition of extra stimuli.
27
In contrast, the addition of caffeine initially resulted in episodes
of both AT and AF during regular pacing and an increased incidence
of arrhythmogenic phenomena during PES in intact hearts, but this
effect disappeared over the next 5 min. These ﬁndings are directly
comparable with the early appearance of diastolic Ca
2+ release
attributable to an enhanced CICR, but their subsequent disappearance
is due to the consequent SR Ca
2+ reduction. This would be consistent
with the correlations between the observed abolition of atrial
arrhythmogenicity in the whole hearts by CPA, which appeared
to reduce myocyte SR Ca
2+ even in the presence of caffeine.
Finally, the effects of nifedipine in inhibiting caffeine-induced
arrhythmogenesis were clearly correlated with its actions in reducing
extracellular Ca
2+ entry, which would similarly reduce CICR, albeit
through a different mechanism.
The presence of caffeine continued to result in prolonged Ca
2+
transient kinetics at the cellular level, as evidenced in our observations
of increased FWHM values despite the reduced Ca
2+ peaks. Never-
theless, such changes in FWHM indicate changes in the kinetics as
opposed to the quantity of Ca
2+ release. They conﬁrm actions of
caffeine in atrial cells not shared by the other agents tested. Thus,
CPA and nifedipine alone, thought to act primarily on SR Ca
2+
reuptake and voltage-dependent Ca
2+ entry, respectively, produced
no observable changes in FWHM. Thus, the results are consistent
with the action of caffeine on CICR that has been established
previously for ventricular cells.
28 Finally, the actions of caffeine,
CPA and nifedipine together on the heterogeneity of the observed
Ca
2+ signals also implicate changes in CICR: caffeine abolished such
heterogeneities, whereas CPA and nifedipine did not.
Taken together, the ﬁndings from single cells and intact hearts
suggest acute atrial arrhythmogenic phenomena that are dependent
on a diastolic release of SR Ca
2+, itself dependent upon a ﬁnite SR
Ca
2+ store and initiation of Ca
2+ entry, both of which may then offer
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We have demonstrated that caffeine produces early arrhythmogenesis
in intact hearts. This correlates with the early appearance of diastolic
Ca
2+ transients in single cells, suggesting an immediate cause for this
arrhythmogenesis. However, caffeine also produces a progressive
decline in Ca
2+ release, consistent with a depletion of cellular SR
Ca
2+ stores. It is then possible to demonstrate increased FWHM, not
seen either when SR Ca
2+ is depleted by CPA or in the presence of
nifedipine. This is consistent with an action of caffeine on atrial
CICR and possible roles of this CICR in atrial arrhythmogenesis.
Therefore, the ﬁndings of the present study directly complement
earlier studies that explored the effects of pharmacological changes
of Ca
2+ homeostasis.
28,36
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